Terms: = Lung cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Prognosis
327 results:
1. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.
Li J; Ma X; Xu F; Yan Y; Chen W
Pharm Biol; 2024 Dec; 62(1):314-325. PubMed ID: 38571483
[TBL] [Abstract] [Full Text] [Related]
2. Silencing of circ_0088036 inhibits growth and invasion of lung adenocarcinoma through miR-203/SP1 axis.
Liu X; Feng Y; Wang L; Shi L; Ji K; Hu N; Du Y; Liu M; Wang M
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23684. PubMed ID: 38533528
[TBL] [Abstract] [Full Text] [Related]
3. PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative Breast cancer by Activating Notch Signaling.
Li B; Huang L; Ruan J
Rev Invest Clin; 2024; 76(1):45-59. PubMed ID: 38442372
[TBL] [Abstract] [Full Text] [Related]
4. MicroRNA (let-7b-5p)-targeted DARS2 regulates lung adenocarcinoma growth by PI3K/AKT signaling pathway.
Xu Y; Chen X
Oncol Res; 2024; 32(3):517-528. PubMed ID: 38361754
[TBL] [Abstract] [Full Text] [Related]
5. Exosomal long non-coding RNA MALAT1: a candidate of liquid biopsy in monitoring of Wilms' tumor.
Sharma D; Singh A; Wilson C; Swaroop P; Kumar S; Yadav DK; Jain V; Agarwala S; Husain M; Sharawat SK
Pediatr Surg Int; 2024 Feb; 40(1):57. PubMed ID: 38353772
[TBL] [Abstract] [Full Text] [Related]
6. Regulation of overexpression lncRNA ATP2B1-AS1 on lung adenocarcinoma progression.
Chen S; Huang C; Jin E
J Cardiothorac Surg; 2024 Feb; 19(1):88. PubMed ID: 38347625
[TBL] [Abstract] [Full Text] [Related]
7. MAP4 acts as an oncogene and prognostic marker and affects radioresistance by mediating epithelial-mesenchymal transition in lung adenocarcinoma.
Xia X; Ge Y; Ge F; Gu P; Liu Y; Li P; Xu P
J Cancer Res Clin Oncol; 2024 Feb; 150(2):88. PubMed ID: 38341398
[TBL] [Abstract] [Full Text] [Related]
8. sPD-L1 and sPD-L2 in plasma of patients with lung cancer and their clinical significance.
Han S; Zhang Y; Yuan J; Wu Y; Zhou Y; Zhou Y; Li X; Zhou S
Cytokine; 2024 Apr; 176():156532. PubMed ID: 38330638
[TBL] [Abstract] [Full Text] [Related]
9. [TRIP13 Enhances Radioresistance of lung Adenocarcinoma Cells
through the Homologous Recombination Pathway].
Ge S; Gu R; Yang X; Xu C; Wang S; Zhu G
Zhongguo Fei Ai Za Zhi; 2024 Jan; 27(1):1-12. PubMed ID: 38296621
[TBL] [Abstract] [Full Text] [Related]
10. RNF213 inhibits migration in lung adenocarcinoma cell.
Liu X; Zeng H; Li Z; Wei C; Zhang Z; Liu X; Chen N
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):286-292. PubMed ID: 38279417
[TBL] [Abstract] [Full Text] [Related]
11. SLCO4A1, as a novel prognostic biomarker of non‑small cell lung cancer, promotes cell proliferation and migration.
Li S; Li Z; Huang L; Geng Z; Li F; Wu B; Sheng Y; Xu Y; Li B; Xu Y; Gu Z; Qi Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38275113
[TBL] [Abstract] [Full Text] [Related]
12. Overexpression of MTFR1 promotes cancer progression and drug-resistance on cisplatin and is related to the immune microenvironment in lung adenocarcinoma.
Li QY; Guo Q; Luo WM; Luo XY; Ji YM; Xu LQ; Guo JL; Shi RS; Li F; Lin CY; Zhang J; Ke D
Aging (Albany NY); 2024 Jan; 16(1):66-88. PubMed ID: 38170222
[TBL] [Abstract] [Full Text] [Related]
13. Primary pulmonary adenoid cystic carcinoma: A clinicopathological study of 64 patients.
Tan X; Xu T; Shen W; Ai C; Zhang W; Tang X; Luo F; Zhou Q
Thorac Cancer; 2024 Feb; 15(5):386-393. PubMed ID: 38148673
[TBL] [Abstract] [Full Text] [Related]
14. Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature.
Bradová M; Mosaieby E; Michal M; Vaněček T; Ing SK; Grossmann P; Koshyk O; Kinkor Z; Laciok Š; Nemcová A; Straka Ľ; Farkas M; Michal M; Švajdler M
Histopathology; 2024 Apr; 84(5):776-793. PubMed ID: 38114270
[TBL] [Abstract] [Full Text] [Related]
15. Comprehensive study of clinicopathological and immune cell infiltration and lactate dehydrogenase expression in patients with thymic epithelial tumours.
Ying J; Huang Y; Ye X; Zhang Y; Yao Q; Wang J; Yang X; Yu C; Guo Y; Zhang X; Lv Q; Wang C; Mao W; Zhao A
Int Immunopharmacol; 2024 Jan; 126():111205. PubMed ID: 38029550
[TBL] [Abstract] [Full Text] [Related]
16. A2ML1 Inhibits Esophageal Squamous Cell Carcinoma Progression and Serves as a Novel Prognostic Biomarker.
Zhang X; Tang C; Lian J; Jiang Y
Can J Gastroenterol Hepatol; 2023; 2023():5557546. PubMed ID: 37954860
[TBL] [Abstract] [Full Text] [Related]
17.
Zheng Y; Zhang Z; Li X; Wu L; Liu X; Liu L; Chen J; Wei D
Front Biosci (Landmark Ed); 2023 Oct; 28(10):257. PubMed ID: 37919058
[TBL] [Abstract] [Full Text] [Related]
18. POU2F3-Expressing Small Cell lung Carcinoma and Large Cell Neuroendocrine Carcinoma Show Morphologic and Phenotypic Overlap.
Jimbo N; Ohbayashi C; Takeda M; Fujii T; Mitsui S; Tsukamoto R; Tanaka Y; Itoh T; Maniwa Y
Am J Surg Pathol; 2024 Jan; 48(1):4-15. PubMed ID: 37904277
[TBL] [Abstract] [Full Text] [Related]
19. LncRNA RP11-58O9.2 predicts poor prognosis and promotes progression of non-small cell lung cancer.
Miao X; Xi W; Bao Y
J Int Med Res; 2023 Oct; 51(10):3000605231206295. PubMed ID: 37871619
[TBL] [Abstract] [Full Text] [Related]
20. Bronchial oncocytic carcinoma in an adult: a case report and literature review.
Shen YF; Wang CL; Chu ZG; Cao YD; Luo Y; Zhang YL; Cao YJ
BMC Pulm Med; 2023 Oct; 23(1):375. PubMed ID: 37803309
[TBL] [Abstract] [Full Text] [Related]
[Next]